Description
The abstract proposes that systemic inflammation and inflammaging prime the immune system to amplify neuroinflammation, but the precise molecular pathways connecting peripheral immune activation to brain-specific inflammatory responses remain unclear. Understanding these mechanisms is critical for developing targeted interventions that modulate peripheral inflammation without compromising protective immune functions.
Gap type: unexplained_observation Source paper: Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease. (2025, Immunity & ageing : I & A, PMID:40841660)
Resolution criteria
Resolution requires: (1) Parallel measurement of peripheral inflammation markers (IL-6, CRP, IL-1beta in plasma, n>=50 AD vs n>=50 controls) and central inflammation markers (CSF cytokines, TSPO-PET imaging) in the same cohort, establishing peripheral-central correlation at r>=0.5; (2) Mechanistic identification: >=2 specific peripheral cytokines or immune cell populations sufficient to induce central effects when administered peripherally in animal models; (3) Intervention study: anti-inflammatory treatment in humans or animals showing that reducing peripheral inflammation reduces central neuroinflammation (TSPO-PET or CSF markers) by >=30%. Peripheral-central correlation without identifying specific molecular mediators is insufficient.